Q: Can you please comment on Collegium Pharmaceutical (NASDAQ:COLL). I know you do not cover use stocks but I would appreciate any input you may have. The stock is down 50% ytd and reports earnings in the next 2 weeks.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.